Anxiolytic-like effects of the selective mGlu5 receptor antagonist MPEP in punished responding

被引：0
|
作者：
Spooren, W
Vivian, J
Ballard, TF
机构：
[1] Hoffmann La Roche AG, Discovery Biol Neurosci, Basel, Switzerland
[2] Hoffmann La Roche, Discovery Biol Neurosci, Palo Alto, CA USA
来源：
NEUROPHARMACOLOGY | 2002年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
133
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [21] Glutamate mGlu5 receptor antagonist, MPEP, reduces the quinpirole-induced compulsive-like checking in rats
    Gok, Sule
    Demet, Mehmet Murat
    Ozturk, Zeynep
    [J]. JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2017, 15 : 13 - 18
  • [22] Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent
    Stachowicz, K.
    Chojnacka-Wojcik, E.
    Klak, K.
    Pilc, A.
    [J]. NEUROPHARMACOLOGY, 2007, 52 (02) : 306 - 312
  • [23] Description of a clinically validated Anxiolytic with mGlu5 antagonist properties
    Porter, R
    Jaeschke, G
    Spooren, W
    Ballard-Yardy, T
    Prinssen, E
    Muehlemann, A
    Wichmann, J
    Kolczewski, S
    Buettelmann, B
    Viera, E
    Mutel, V
    Malherbe, P
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S30 - S31
  • [24] Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat
    Cavas, Maria
    Scesa, Gianluigi
    Francisco Navarro, Jose
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 18 - 25
  • [25] Fenobam:: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity
    Porter, RHP
    Jaeschke, G
    Spooren, W
    Ballard, TM
    Büttelmann, B
    Kolczewski, S
    Peters, JU
    Prinssen, E
    Wichmann, J
    Vieira, E
    Mühlemann, A
    Gatti, S
    Mutel, V
    Malherbe, P
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02): : 711 - 721
  • [26] Antidepressant-and anxiolytic-like effects of group III mGlu receptor ligand
    Pilc, A.
    Nowak, G.
    Wieronska, J. M.
    Stachowicz, K.
    Palucha-Poniewiera, A.
    Branski, P.
    [J]. NEUROPHARMACOLOGY, 2008, 55 (04) : 617 - 618
  • [27] Antagonism of the mGlu5 agonist 2-chloro-5-hydroxyphenylglycine by the novel selective mGlu5 antagonist 6-methyl-2(phenylethynyl)-pyridine (MPEP) in the thalamus
    Salt, TE
    Binns, KE
    Turner, JP
    Gasparini, F
    Kuhn, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (05) : 1057 - 1059
  • [28] The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: Significance for the use as anxiolytic/antidepressant drug
    Inta, Dragos
    Filipovic, Dragana
    Lima-Ojeda, Juan M.
    Dormann, Christof
    Pfeiffer, Natascha
    Gasparini, Fabrizio
    Gass, Peter
    [J]. NEUROPHARMACOLOGY, 2012, 62 (5-6) : 2034 - 2039
  • [29] Description of a clinically validated anxiolytic with mGlu5 antagonist properties.
    Porter, RHP
    Jaeschke, G
    Spooren, W
    Ballard-Yardy, T
    Prinssen, E
    Muehlemann, A
    Wichmann, J
    Kolczewski, S
    Buettelmann, B
    Viera, E
    Mutel, V
    Malherbe, P
    [J]. NEUROPHARMACOLOGY, 2005, 49 : 267 - 267
  • [30] The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning
    Jacob, Wolfgang
    Gravius, Andreas
    Pietraszek, Malgorzata
    Nagel, Jens
    Belozertseva, Irina
    Shekunova, Elena
    Malyshkin, Andrey
    Greco, Sergio
    Barberi, Caroline
    Danysz, Wojciech
    [J]. NEUROPHARMACOLOGY, 2009, 57 (02) : 97 - 108
12345